OPM's revenues are mainly composed of a milestone of €7 M in the context of the partnership with SERVIER laboratories on LRRK2 (option exercised upon entry into clinical trials) and an up-front of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results